Safinamide
An α-aminoamide derivatives, Safinamide’s active ingredient selectively and reversibly inhibits monoaminoxidase B, leading to an increase of dopamine concentration in the synaptic gap. This is why it is predominantly used to treat Parkinson’s Disease.
Axano Pharmaceuticals Ltd
- malta europe
- admin @axanopharmamalta.com
- [email protected]
- contact details
- Malta +356 27780827